论文部分内容阅读
ＣＤ８２为ＴＭ４ＳＦ的成员，其结构为细胞膜糖蛋白。最近研究表明ＣＤ８２蛋白对多种肿瘤的转移具有抑制作用。本文综述ＣＤ８２在非小细胞肺癌（ＮＳＣＬＣ）中的表达及其与ＮＳＣＬＣ患者预后的关系
CD82 is a member of TM4SF and its structure is a cell membrane glycoprotein. Recent studies have shown that CD82 protein has inhibitory effects on the metastasis of various tumors. This article reviews the expression of CD82 in non-small cell lung cancer (NSCLC) and its relationship with prognosis of patients with NSCLC.